| Literature DB >> 28142032 |
Ribeka Takachi1, Manami Inoue2, Yumi Sugawara3, Ichiro Tsuji3, Shoichiro Tsugane4, Hidemi Ito5, Keitaro Matsuo6, Keitaro Tanaka7, Akiko Tamakoshi8, Tetsuya Mizoue9, Kenji Wakai10, Chisato Nagata11, Shizuka Sasazuki12.
Abstract
BACKGROUND: A series of recent reports from large-scale cohort studies involving more than 100,000 subjects reported no or only very small inverse associations between fruit and vegetable intake and overall cancer incidence, despite having sufficient power to do so. To date, however, no such data have been reported for Asian populations.Entities:
Keywords: Cancer risk; Fruit and vegetable intake; Japanese; Pooled analysis
Mesh:
Year: 2017 PMID: 28142032 PMCID: PMC5376310 DOI: 10.1016/j.je.2016.05.004
Source DB: PubMed Journal: J Epidemiol ISSN: 0917-5040 Impact factor: 3.211
Characteristics of the four cohort studies included in a pooled analysis of fruits and vegetables and the risk of overall cancer incidence.
| Study | Population | Age at baseline survey, years | Year(s) of baseline survey | Population size | Rate of response to baseline questionnaire, % | Method of follow-up | For the present pooled analysis | (Applied Analysis) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age, years | Last follow-up time | Mean duration of follow-up, years | Size of cohort | Number of overall cancer incidence | ||||||||||
| Men | Women | Men | Women | |||||||||||
| JPHC-I | Japanese residents of 5 public health center areas in Japan | 40–59 | 1990 | 61,595 | 82% | Cancer registries and death certificates | 40–59 | 2006 | 15.2 | 20,152 | 21,593 | 2400 | 1681 | (Quintile) |
| 20,298 | 21,807 | 2415 | 1696 | (Frequency) | ||||||||||
| JPHC-II | Japanese residents of 6 public health center areas in Japan | 40–69 | 1993–1994 | 78,825 | 80% | Cancer registries and death certificates | 40–69 | 2006 | 12.0 | 28,933 | 32,031 | 3427 | 1990 | (Quintile) |
| 29,224 | 32,439 | 3461 | 2021 | (Frequency) | ||||||||||
| MIYAGI | Residents of 14 municipalities in Miyagi Prefecture, Japan | 40–64 | 1990 | 47,605 | 92% | Cancer registries and death certificates | 40–64 | 2003 | 12.5 | 20,917 | 22,449 | 2091 | 1381 | (Quintile) |
| 21,042 | 22,709 | 2108 | 1402 | (Frequency) | ||||||||||
| OHSAKI | Beneficiaries of National Health Insurance among residents of 14 municipalities in Miyagi Prefecture, Japan | 40–79 | 1994 | 54,996 | 95% | Cancer registries and death certificates | 40–79 | 2005 | 9.0 | 21,777 | 23,667 | 3042 | 1669 | (Quintile) |
| 21,980 | 23,976 | 3078 | 1691 | (Frequency) | ||||||||||
| 3-pref MIYAGI | Residents of 3 municipalities in Miyagi Prefecture, Japan | 40–98 | 1984 | 31,345 | 94% | Cancer registries and death certificates | 40–98 | 1992 | 7.5 | 13,080 | 15,377 | 1080 | 781 | (Frequency) |
| 3-pref AICHI | Residents of 2 municipalities in Aichi Prefecture, Japan | 40–103 | 1985 | 33,529 | 90% | Cancer registries and death certificates | 40–103 | 2000 | 11.3 | 15,340 | 17,042 | 1587 | 1122 | (Frequency) |
| Total | 40–79 | 1990–94 | 243,021 | 80–95 | 40–79 | 2003–06 | 9.0–15.2 | 91,779 | 99,740 | 10,960 | 6721 | (Quintile) | ||
| 120,964 | 133,350 | 13,729 | 8713 | (Frequency) | ||||||||||
JPHC, Japan Public Health Center-based Prospective Study; MIYAGI, The Miyagi Cohort Study; OHSAKI: The Ohsaki National Health Insurance Cohort Study 3-pref MIYAGI, The Three Prefectures Study - Miyagi portion; 3-pref AICHI, The Three Prefectures Study - Aichi portion. *Sub-analysis based on frequencies of fruit and vegetable intake was independently conducted (Table 5-1, Table 5-2): two cohort studies (3-pref MIYAGI and 3-pref AICHI) which were not suited for the analysis based on energy-adjusted intake because total energy intake could not be calculated from their FFQ were also included. Thus, exclusion criteria (extreme consumption according to total energy intake) in the analysis based on the frequency differed from those based on quintiles of energy-adjusted fruit and vegetable intake.
Pooled analysis of overall cancer incidence according to quintile of fruit and vegetable consumption in Japanese men, 1990–2006.
| Lowest | Second | Third | Fourth | Highest | p for trend | p for heterogeneity | ||
|---|---|---|---|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | for the highest category | for trend | ||
| Number of subjects | 18,354 | 18,358 | 18,355 | 18,358 | 18,354 | |||
| Person-years | 217,070 | 218,667 | 218,957 | 217,783 | 214,059 | |||
| Number of cases | 2081 | 2091 | 2152 | 2288 | 2348 | |||
| ASR (per 100,000) | 1120 | 1110 | 1084 | 1082 | 1080 | |||
| HR1 | 1.0 (Ref.) | 0.98 (0.92, 1.04) | 0.95 (0.88, 1.03) | 0.95 (0.90, 1.01) | 0.95 (0.89, 1.00) | 0.91 | 0.74 | |
| HR2 | 1.0 (Ref.) | 1.01 (0.95, 1.07) | 1.00 (0.93, 1.07) | 1.03 (0.96, 1.09) | 1.04 (0.98, 1.11) | 0.96 | 0.78 | |
| HR3 | 1.0 (Ref.) | 0.97 (0.91, 1.03) | 1.00 (0.93, 1.08) | 1.04 (0.97, 1.11) | 1.04 (0.97, 1.11) | 0.99 | 0.78 | |
| Number of subjects | 18,354 | 18,358 | 18,355 | 18,358 | 18,354 | |||
| Person-years | 217,028 | 217,845 | 218,569 | 218,887 | 214,208 | |||
| Number of cases | 2218 | 2143 | 2156 | 2130 | 2313 | |||
| ASR (per 100,000) | 1160 | 1117 | 1108 | 1022 | 1075 | |||
| HR1 | 1.0 (Ref.) | 0.96 (0.90, 1.02) | 0.94 (0.88, 1.01) | 0.88 (0.81, 0.95) | 0.92 (0.86, 0.97) | < | 0.78 | 0.44 |
| HR2 | 1.0 (Ref.) | 1.01 (0.95, 1.07) | 1.00 (0.94, 1.08) | 0.96 (0.90, 1.02) | 1.03 (0.97, 1.10) | 0.57 | 0.42 | |
| HR3 | 1.0 (Ref.) | 0.98 (0.92, 1.04) | 1.01 (0.94, 1.08) | 0.96 (0.89, 1.04) | 1.03 (0.96, 1.10) | 0.89 | 0.60 | |
| Number of subjects | 18,354 | 18,358 | 18,355 | 18,358 | 18,354 | |||
| Person-years | 217,320 | 217,056 | 218,160 | 218,274 | 215,726 | |||
| Number of cases | 2216 | 2127 | 2043 | 2244 | 2330 | |||
| ASR (per 100,000) | 1167 | 1152 | 1060 | 1076 | 1034 | |||
| HR1 | 1.0 (Ref.) | 0.97 (0.91, 1.03) | 0.90 (0.84, 0.97) | 0.92 (0.85, 0.99) | 0.87 (0.82, 0.93) | < | 0.58 | 0.52 |
| HR2 | 1.0 (Ref.) | 1.01 (0.95, 1.07) | 0.97 (0.91, 1.03) | 1.00 (0.94, 1.06) | 0.99 (0.93, 1.05) | 0.38 | 0.72 | |
| HR3 | 1.0 (Ref.) | 0.99 (0.92, 1.06) | 0.96 (0.90, 1.03) | 0.98 (0.92, 1.05) | 1.00 (0.93, 1.07) | 0.50 | 0.52 | |
| Number of subjects | 18,354 | 18,358 | 18,355 | 18,358 | 18,354 | |||
| Person-years | 217,282 | 218,471 | 218,766 | 218,076 | 213,941 | |||
| Number of cases | 2016 | 2029 | 2203 | 2280 | 2432 | |||
| ASR (per 100,000) | 1083 | 1072 | 1100 | 1092 | 1118 | |||
| HR1 | 1.0 (Ref.) | 0.99 (0.93, 1.05) | 1.02 (0.96, 1.08) | 1.00 (0.94, 1.06) | 1.02 (0.96, 1.08) | 0.92 | 0.88 | |
| HR2 | 1.0 (Ref.) | 1.00 (0.94, 1.07) | 1.04 (0.98, 1.11) | 1.03 (0.97, 1.09) | 1.07 (1.01, 1.14) | 0.81 | 0.86 | |
| HR3 | 1.0 (Ref.) | 0.99 (0.93, 1.06) | 1.03 (0.96, 1.10) | 1.03 (0.96, 1.10) | 1.08 (1.01,1.15) | 0.62 | 0.73 | |
| Number of subjects | 18,354 | 18,358 | 18,355 | 18,358 | 18,354 | |||
| Person-years | 217,262 | 219,134 | 218,069 | 218,261 | 213,810 | |||
| Number of cases | 2025 | 2036 | 2252 | 2278 | 2369 | |||
| ASR (per 100,000) | 1079 | 1061 | 1126 | 1107 | 1091 | |||
| HR1 | 1.0 (Ref.) | 1.00 (0.94, 1.06) | 1.04 (0.96, 1.13) | 1.02 (0.96, 1.08) | 1.02 (0.96, 1.08) | 0.82 | 0.94 | |
| HR2 | 1.0 (Ref.) | 1.02 (0.95, 1.08) | 1.07 (0.997, 1.16) | 1.05 (0.99, 1.12) | 1.07 (1.01, 1.14) | 0.73 | 0.82 | |
| HR3 | 1.0 (Ref.) | 1.02 (0.95, 1.09) | 1.08 (1.01, 1.17) | 1.06 (0.98, 1.14) | 1.08 (1.01, 1.15) | 0.20 | 0.77 | |
| Number of subjects | 18,354 | 18,358 | 18,355 | 18,358 | 18,354 | |||
| Person-years | 216,692 | 218,424 | 218,289 | 217,287 | 215,844 | |||
| Number of cases | 2083 | 2001 | 2157 | 2311 | 2408 | |||
| ASR (per 100,000) | 956 | 1084 | 1106 | 1095 | 1059 | |||
| HR1 | 1.0 (Ref.) | 0.96 (0.91, 1.03) | 1.00 (0.94, 1.06) | 0.98 (0.92, 1.04) | 0.95 (0.89, 1.01) | 0.78 | 0.94 | |
| HR2 | 1.0 (Ref.) | 0.99 (0.93, 1.05) | 1.02 (0.95, 1.09) | 1.03 (0.97, 1.09) | 1.02 (0.96, 1.08) | 0.92 | 0.99 | |
| HR3 | 1.0 (Ref.) | 0.94 (0.89, 1.01) | 1.01 (0.95, 1.08) | 1.04 (0.98, 1.11) | 1.00 (0.94, 1.07) | 0.86 | 0.85 | |
ASR, age-standardized rate; CI, confidence interval; HR, hazard ratio.
HR1 was adjusted for age (continuous), area (for JPHC-I, JPHC-II only). HR2 and 3: further adjusted for total energy intake (quintile), smoking status (never, past, <19, 19–39, or ≥40 cigarettes/day for men), alcohol consumption (non, occasional, <23, 23–45, or ≥46 g ethanol/day), body mass index in kg/m2 (14–18.9, 19–20.9, 21–22.9, 23–24.9, 25–26.9, 27–29.9, or 30–40 kg/m2), history of diabetes mellitus (yes or no), and screening examination (yes or no; any kind of the following cancer screening for JPHC-I: chest X-ray, sputum test, photofluorography, gastrointestinal endoscopy, fecal occult blood test, barium enema, or colonoscopy; any kind of screening examination for JPHC-II; and chest X-ray, gastric cancer examination, Pap smear, mammography, or complete medical checkup for MIYAGI and OHSAKI). HR3 excluded diagnosed or deceased cases of any cancers during the first 3 years of follow-up. Linear trends across quintiles of fruit and vegetable intake were tested using 0 to 4 for each quintile as an ordinal variable.
Pooled analysis of overall cancer incidence according to quintile of fruit and vegetable consumption in Japanese women, 1990–2006.
| Lowest | Second | Third | Fourth | Highest | p for trend | p for heterogeneity | ||
|---|---|---|---|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | for the highest category | For trend | ||
| Number of subjects | 19,946 | 19,949 | 19,949 | 19,949 | 19,947 | |||
| Person-years | 245,257 | 246,517 | 248,367 | 246,836 | 245,414 | |||
| Number of cases | 1331 | 1269 | 1313 | 1382 | 1426 | |||
| ASR (per 100,000) | 579 | 544 | 552 | 573 | 583 | |||
| HR1 | 1.0 (Ref.) | 0.95 (0.87, 1.04) | 0.96 (0.88, 1.06) | 1.00 (0.92, 1.08) | 1.01 (0.94, 1.09) | 0.85 | 0.86 | |
| HR2 | 1.0 (Ref.) | 0.97 (0.89, 1.05) | 0.98 (0.90, 1.07) | 1.01 (0.94, 1.09) | 1.02 (0.94, 1.10) | 0.70 | 0.78 | |
| HR3 | 1.0 (Ref.) | 0.98 (0.90, 1.07) | 1.00 (0.91, 1.09) | 1.03 (0.95, 1.12) | 1.05 (0.96, 1.14) | 0.41 | 0.52 | |
| Number of subjects | 19,946 | 19,949 | 19,949 | 19,949 | 19,947 | |||
| Person-years | 244,973 | 246,783 | 248,180 | 247,496 | 244,959 | |||
| Number of cases | 1375 | 1278 | 1321 | 1301 | 1446 | |||
| ASR (per 100,000) | 588 | 554 | 554 | 539 | 598 | |||
| HR1 | 1.0 (Ref.) | 0.94 (0.87, 1.02) | 0.95 (0.88, 1.03) | 0.93 (0.86, 1.00) | 1.02 (0.94, 1.10) | 0.82 | 0.86 | |
| HR2 | 1.0 (Ref.) | 0.95 (0.88, 1.02) | 0.96 (0.89, 1.04) | 0.94 (0.87, 1.01) | 1.03 (0.95, 1.11) | 0.80 | 0.77 | |
| HR3 | 1.0 (Ref.) | 0.95 (0.88, 1.04) | 0.99 (0.91, 1.08) | 0.94 (0.85, 1.03) | 1.05 (0.97, 1.14) | 0.59 | 0.46 | |
| Number of subjects | 19,946 | 19,949 | 19,949 | 19,949 | 19,947 | |||
| Person-years | 244,709 | 245,699 | 247,885 | 247,934 | 246,163 | |||
| Number of cases | 1374 | 1262 | 1327 | 1312 | 1446 | |||
| ASR (per 100,000) | 589 | 546 | 563 | 542 | 592 | |||
| HR1 | 1.0 (Ref.) | 0.94 (0.86, 1.02) | 0.97 (0.90, 1.04) | 0.93 (0.86, 1.00) | 1.01 (0.94, 1.09) | 0.93 | 0.86 | |
| HR2 | 1.0 (Ref.) | 0.95 (0.87, 1.02) | 0.98 (0.91, 1.06) | 0.94 (0.86, 1.01) | 1.02 (0.95, 1.10) | 0.89 | 0.85 | |
| HR3 | 1.0 (Ref.) | 0.93 (0.85, 1.02) | 0.99 (0.91, 1.08) | 0.93 (0.85, 1.02) | 1.03 (0.94, 1.12) | 0.91 | 0.68 | |
| Number of subjects | 19,946 | 19,949 | 19,949 | 19,949 | 19,947 | |||
| Person-years | 245,417 | 246,791 | 247,663 | 246,524 | 245,995 | |||
| Number of cases | 1327 | 1328 | 1274 | 1402 | 1390 | |||
| ASR (per 100,000) | 576 | 572 | 539 | 584 | 563 | |||
| HR1 | 1.0 (Ref.) | 1.00 (0.92, 1.09) | 0.94 (0.87, 1.02) | 1.01 (0.93, 1.10) | 0.98 (0.91, 1.05) | 0.72 | 0.74 | |
| HR2 | 1.0 (Ref.) | 1.01 (0.94, 1.09) | 0.95 (0.88, 1.03) | 1.02 (0.94, 1.11) | 0.98 (0.91, 1.06) | 0.65 | 0.72 | |
| HR3 | 1.0 (Ref.) | 1.00 (0.90, 1.12) | 0.95 (0.87, 1.04) | 1.04 (0.93, 1.16) | 0.99 (0.91, 1.07) | 0.54 | 0.63 | |
| Number of subjects | 19,946 | 19,949 | 19,949 | 19,949 | 19,947 | |||
| Person-years | 245,703 | 247,306 | 247,225 | 246,562 | 245,594 | |||
| Number of cases | 1329 | 1313 | 1363 | 1317 | 1399 | |||
| ASR (per 100,000) | 585 | 582 | 577 | 550 | 569 | |||
| HR1 | 1.00 (0.90, 1.10) | 1.02 (0.94, 1.10) | 0.97 (0.89, 1.04) | 1.00 (0.92, 1.08) | 0.34 | 0.57 | ||
| HR2 | 1.01 (0.92, 1.11) | 1.03 (0.96, 1.12) | 0.98 (0.91, 1.06) | 1.01 (0.92, 1.10) | 0.28 | 0.50 | ||
| HR3 | 1.01 (0.93, 1.10) | 1.03 (0.95, 1.13) | 0.97 (0.89, 1.06) | 1.01 (0.91, 1.12) | 0.22 | 0.29 | ||
| Number of subjects | 19,946 | 19,949 | 19,949 | 19,949 | 19,947 | |||
| Person-years | 244,769 | 246,500 | 246,852 | 247,565 | 246,705 | |||
| Number of cases | 1365 | 1286 | 1325 | 1354 | 1391 | |||
| ASR (per 100,000) | 595 | 558 | 566 | 561 | 557 | |||
| HR1 | 1.0 (Ref.) | 0.95 (0.88, 1.03) | 0.96 (0.86, 1.08) | 0.95 (0.88, 1.02) | 0.95 (0.88, 1.02) | 0.93 | 0.98 | |
| HR2 | 1.0 (Ref.) | 0.96 (0.89, 1.04) | 0.98 (0.86, 1.11) | 0.96 (0.89, 1.04) | 0.96 (0.89, 1.03) | 0.89 | 0.98 | |
| HR3 | 1.0 (Ref.) | 0.94 (0.87, 1.03) | 0.98 (0.84, 1.15) | 0.96 (0.89, 1.05) | 0.95 (0.88, 1.04) | 0.96 | 0.96 | |
ASR, age-standardized rate; CI, confidence interval; HR, hazard ratio.
HR1 was adjusted for age (continuous), area (for JPHC-I, JPHC-II only). HR2 and 3: further adjusted for total energy intake (quintile), smoking status (never, past, or current), alcohol consumption (non, occasional, <23, 23–45, or ≥46 g ethanol/day), body mass index in kg/m2 (14–18.9, 19–20.9, 21–22.9, 23–24.9, 25–26.9, 27–29.9, or 30–40 kg/m2), history of diabetes mellitus (yes or no), and screening examination (yes or no; any kind of the following cancer screening for JPHC-I: chest X-ray, sputum test, photofluorography, gastrointestinal endoscopy, fecal occult blood test, barium enema, or colonoscopy; any kind of screening examination for JPHC-II; and chest X-ray, gastric cancer examination, Pap smear, mammography, or complete medical checkup for MIYAGI and OHSAKI). HR3 excluded diagnosed or deceased cases of any cancers during the first 3 years of follow-up. Linear trends across quintiles of fruit and vegetable intake were tested using 0 to 4 for each quintile as an ordinal variable.
Pooled analysis of overall cancer incidence according to quintile of fruit and vegetable consumption, stratified by smoking status, in Japanese men and women.
| Lowest | Second | Third | Fourth | Highest | p for trend | p for heterogeneity | ||
|---|---|---|---|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | for the highest category | for trend | ||
| Men (19,299 never smokers and 70,924 ever smokers) | ||||||||
| Never smokers | ||||||||
| Number of cases | 324 | 344 | 284 | 364 | 357 | |||
| HR2 | 1.0 (Ref.) | 1.11 (0.94, 1.3) | 0.92 (0.77, 1.1) | 1.08 (0.92, 1.28) | 1.10 (0.93, 1.29) | 0.88 | 0.88 | |
| Ever smokers | ||||||||
| Number of cases | 1825 | 1736 | 1820 | 1761 | 1957 | |||
| HR2 | 1.0 (Ref.) | 0.99 (0.92, 1.05) | 1.01 (0.93, 1.1) | 0.95 (0.89, 1.01) | 1.01 (0.95, 1.08) | 0.56 | 0.39 | |
| Never smokers | ||||||||
| Number of cases | 311 | 292 | 321 | 368 | 381 | |||
| HR2 | 1.0 (Ref.) | 0.91 (0.77, 1.07) | 0.96 (0.82, 1.12) | 1.09 (0.93, 1.27) | 1.06 (0.91, 1.24) | 0.49 | 0.79 | |
| Ever smokers | ||||||||
| Number of cases | 1650 | 1706 | 1828 | 1883 | 2032 | |||
| HR2 | 1.0 (Ref.) | 1.02 (0.95, 1.09) | 1.05 (0.98, 1.12) | 1.02 (0.96, 1.09) | 1.07 (1.00, 1.15) | 0.81 | 0.78 | |
| Women (80,600 never smokers and 8300 ever smokers) | ||||||||
| Never smokers | ||||||||
| Number of cases | 1084 | 1039 | 1044 | 1061 | 1153 | |||
| HR2 | 1.0 (Ref.) | 0.97 (0.89, 1.06) | 0.97 (0.89, 1.06) | 0.96 (0.88, 1.04) | 1.04 (0.95, 1.13) | 0.54 | 0.51 | |
| Ever smokers | ||||||||
| Number of cases | 134 | 119 | 105 | 122 | 119 | |||
| HR | 1.0 (Ref.) | 0.86 (0.67, 1.11) | 0.86 (0.66, 1.11) | 0.92 (0.69, 1.22) | 0.90 (0.70, 1.15) | 0.74 | 0.78 | |
| Never smokers | ||||||||
| Number of cases | 1058 | 1053 | 1014 | 1159 | 1097 | |||
| HR | 1.0 (Ref.) | 0.99 (0.90, 1.1) | 0.94 (0.86, 1.03) | 1.03 (0.95, 1.12) | 0.96 (0.87, 1.05) | 0.35 | 0.91 | |
| Ever smokers | ||||||||
| Number of cases | 108 | 132 | 121 | 109 | 129 | |||
| HR | 1.0 (Ref.) | 1.19 (0.93, 1.53) | 1.07 (0.78, 1.47) | 0.93 (0.64, 1.37) | 1.10 (0.85, 1.42) | 0.75 | 0.53 | |
Hazard ratios were adjusted for age (continuous), area (for JPHC-I, JPHC-II only), total energy intake (quintile), smoking status (never, past, <19, 19–39, or ≥40 cigarette/day for men; never, past, or current for women), alcohol consumption (non, occasional, <23, 23–45, or ≥46 g ethanol/day), body mass index in kg/m2 (14–18.9, 19–20.9, 21–22.9, 23–24.9, 25–26.9, 27–29.9, or 30–40 kg/m2), history of diabetes mellitus (yes or no), and screening examination (yes or no; any kind of the following cancer screening for JPHC-I: chest X-ray, sputum test, photofluorography, gastrointestinal endoscopy, fecal occult blood test, barium enema, or colonoscopy; any kind of screening examination for JPHC-II; and chest X-ray, gastric cancer examination, Pap smear, mammography, or complete medical checkup for MIYAGI and OHSAKI). Linear trends across quintiles of fruit and vegetable intake were tested using 0 to 4 for each quintile as an ordinal variable.
Pooled analysis of overall cancer incidence according to quintile of fruit and vegetable consumption, stratified by alcohol drinking, in Japanese men and women.
| Lowest | Second | Third | Fourth | Highest | p for trend | p for heterogeneity | ||
|---|---|---|---|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | for the highest category | For trend | ||
| Men (29,057 non-drinkers or occasional drinkers and 59,737 drinkers) | ||||||||
| Non-drinkers or occasional drinkers | ||||||||
| Number of cases | 693 | 634 | 665 | 702 | 790 | |||
| HR2 | 1.0 (Ref.) | 0.95 (0.77, 1.16) | 0.95 (0.79, 1.13) | 0.98 (0.88, 1.09) | 1.06 (0.95, 1.17) | 0.88 | 0.86 | |
| Drinkers | ||||||||
| Number of cases | 1460 | 1384 | 1436 | 1348 | 1458 | |||
| HR2 | 1.0 (Ref.) | 1.00 (0.89, 1.11) | 1.04 (0.97, 1.12) | 0.93 (0.87, 1.01) | 1.00 (0.93, 1.08) | 0.60 | 0.22 | |
| Non-drinkers or occasional drinkers | ||||||||
| Number of cases | 639 | 638 | 687 | 726 | 794 | |||
| HR2 | 1.0 (Ref.) | 1.01 (0.91, 1.13) | 1.03 (0.92, 1.15) | 1.00 (0.90, 1.12) | 1.11 (0.998, 1.23) | 0.55 | 0.73 | |
| Drinkers | ||||||||
| Number of cases | 1301 | 1289 | 1436 | 1500 | 1560 | |||
| HR2 | 1.0 (Ref.) | 0.97 (0.90, 1.05) | 1.04 (0.97, 1.12) | 1.03 (0.96, 1.11) | 1.05 (0.97, 1.13) | 0.45 | 0.46 | |
| Women (79,055 nondrinkers or occasional drinkers and 11,369 drinkers) | ||||||||
| Non-drinkers or occasional drinkers | ||||||||
| Number of cases | 1129 | 1042 | 1068 | 1074 | 1142 | |||
| HR2 | 1.0 (Ref.) | 0.93 (0.86, 1.02) | 0.95 (0.87, 1.04) | 0.94 (0.86, 1.02) | 0.99 (0.91, 1.08) | 0.58 | 0.45 | |
| Drinkers | ||||||||
| Number of cases | 127 | 115 | 118 | 132 | 144 | |||
| HR2 | 1.0 (Ref.) | 1.01 (0.70, 1.45) | 0.96 (0.74, 1.24) | 1.11 (0.84, 1.45) | 1.16 (0.90, 1.49) | 0.74 | 0.72 | |
| Non-drinkers or occasional drinkers | ||||||||
| Number of cases | 1078 | 1074 | 1031 | 1152 | 1120 | |||
| HR2 | 1.0 (Ref.) | 0.97 (0.84, 1.13) | 0.94 (0.86, 1.02) | 1.01 (0.91, 1.11) | 0.99 (0.87, 1.13) | 0.20 | 0.92 | |
| Drinkers | ||||||||
| Number of cases | 128 | 121 | 121 | 132 | 134 | |||
| HR2 | 1.0 (Ref.) | 0.97 (0.75, 1.24) | 0.94 (0.73, 1.21) | 1.06 (0.83, 1.36) | 0.97 (0.76, 1.25) | 0.40 | 0.17 | |
Hazard ratios were adjusted for age (continuous), area (for JPHC-I, JPHC-II only), total energy intake (quintile), smoking status (never, past, <19, 19–39, or ≥40 cigarette/day for men; never, past, or current for women), alcohol consumption (non, occasional, <23, 23–45, or ≥46 g ethanol/day), body mass index in kg/m2 (14–18.9, 19–20.9, 21–22.9, 23–24.9, 25–26.9, 27–29.9, or 30–40 kg/m2), history of diabetes mellitus (yes or no), and screening examination (yes or no; any kind of the following cancer screening for JPHC-I: chest X-ray, sputum test, photofluorography, gastrointestinal endoscopy, fecal occult blood test, barium enema, or colonoscopy; any kind of screening examination for JPHC-II; and chest X-ray, gastric cancer examination, Pap smear, mammography, or complete medical checkup for MIYAGI and OHSAKI). Linear trends across quintiles of fruit and vegetable intake were tested using 0 to 4 for each quintile as an ordinal variable.
Pooled analysis of total cancer incidence according to frequency of fruit and vegetable intake among 120,964 Japanese men, 1990–2006.
| Almost never | 1-2/week | 3-4/week | Almost daily | p for trend | p for heterogeneity | ||
|---|---|---|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | for the highest category | For trend | ||
| Number of subjects | 1419 | 2399 | 4084 | 111,961 | |||
| Person-years | 14,022 | 27,155 | 46,281 | 1,260,207 | |||
| Number of cases | 186 | 259 | 403 | 12,747 | |||
| ASR (per 100,000) | 1168 | 1034 | 1111 | 1096 | |||
| HR1 | 1.0 (Ref.) | 0.91 (0.73, 1.13) | 0.89 (0.74, 1.07) | 0.93 (0.80, 1.07) | 0.41 | 0.61 | |
| HR2 | 1.0 (Ref.) | 0.92 (0.72, 1.16) | 0.91 (0.76, 1.1) | 0.97 (0.83, 1.13) | 0.37 | 0.54 | |
| HR3 | 1.0 (Ref.) | 0.91 (0.72, 1.15) | 0.99 (0.80, 1.22) | 1.04 (0.88, 1.24) | 0.81 | 0.70 | |
| Number of subjects | 21,334 | 20,521 | 25,347 | 53,251 | |||
| Person-years | 235,870 | 238,040 | 291,188 | 588,616 | |||
| Number of cases | 2433 | 2170 | 2735 | 6325 | |||
| ASR (per 100,000) | 1139 | 1106 | 1086 | 1076 | |||
| HR1 | 1.0 (Ref.) | 0.99 (0.90, 1.08) | 0.95 (0.89, 1.01) | 0.94 (0.88, 0.997) | 0.17 | 0.45 | |
| HR2 | 1.0 (Ref.) | 1.01 (0.92, 1.1) | 0.99 (0.93, 1.05) | 1.02 (0.96, 1.08) | 0.21 | 0.37 | |
| HR3 | 1.0 (Ref.) | 1.02 (0.92, 1.13) | 1.00 (0.92, 1.07) | 1.03 (0.95, 1.12) | 0.07 | 0.28 | |
| Number of subjects | 24,401 | 19,825 | 17,380 | 30,938 | |||
| Person-years | 279,605 | 245,514 | 214,934 | 354,828 | |||
| Number of cases | 2916 | 2204 | 2056 | 3886 | |||
| ASR (per 100,000) | 1188 | 1176 | 1158 | 1087 | |||
| HR1 | 1.0 (Ref.) | 0.94 (0.89, 1.00) | 0.92 (0.86, 0.99) | 0.89 (0.85, 0.94) | < | 0.45 | 0.48 |
| HR2 | 1.0 (Ref.) | 0.97 (0.91, 1.03) | 0.98 (0.92, 1.04) | 0.98 (0.93, 1.03) | 0.80 | 0.92 | |
| HR3 | 1.0 (Ref.) | 0.96 (0.89, 1.03) | 0.97 (0.91, 1.04) | 1.00 (0.87, 1.15) | <0.01 | 0.74 | |
| Number of subjects | 2641 | 3942 | 6530 | 107,041 | |||
| Person-years | 27,695 | 44,538 | 73,935 | 1,204,774 | |||
| Number of cases | 335 | 400 | 644 | 12,254 | |||
| ASR (per 100,000) | 1155 | 1049 | 1037 | 1099 | |||
| HR1 | 1.0 (Ref.) | 0.92 (0.79, 1.06) | 0.92 (0.80, 1.05) | 0.96 (0.86, 1.07) | 0.64 | 0.99 | |
| HR2 | 1.0 (Ref.) | 0.93 (0.80, 1.08) | 0.94 (0.82, 1.07) | 0.99 (0.89, 1.11) | 0.73 | 0.97 | |
| HR3 | 1.0 (Ref.) | 0.96 (0.81, 1.14) | 0.98 (0.84, 1.14) | 1.04 (0.91, 1.18) | 0.94 | 0.77 | |
| Number of subjects | 6318 | 5797 | 15,681 | 92,736 | |||
| Person-years | 68,320 | 65,009 | 180,846 | 1,040,467 | |||
| Number of cases | 756 | 587 | 1618 | 10,717 | |||
| ASR (per 100,000) | 1160 | 1068 | 1050 | 1099 | |||
| HR1 | 1.0 (Ref.) | 0.91 (0.81, 1.01) | 0.95 (0.87, 1.05) | 0.96 (0.89, 1.04) | 0.93 | 0.99 | |
| HR2 | 1.0 (Ref.) | 0.91 (0.82, 1.01) | 0.97 (0.89, 1.07) | 0.99 (0.92, 1.07) | 0.97 | 0.98 | |
| HR3 | 1.0 (Ref.) | 0.92 (0.79, 1.07) | 0.99 (0.90, 1.10) | 1.00 (0.91, 1.09) | 0.79 | 0.86 | |
| Number of subjects | 12,418 | 15,054 | 27,422 | 65,748 | |||
| Person-years | 132,772 | 162,075 | 306,687 | 754,274 | |||
| Number of cases | 1396 | 1509 | 2920 | 7869 | |||
| ASR (per 100,000) | 1131 | 1057 | 1088 | 1097 | |||
| HR1 | 1.0 (Ref.) | 0.95 (0.82, 1.10) | 0.96 (0.89, 1.04) | 0.94 (0.86, 1.03) | 0.07 | 0.49 | |
| HR2 | 1.0 (Ref.) | 0.96 (0.82, 1.12) | 0.99 (0.92, 1.05) | 0.99 (0.91, 1.08) | 0.13 | 0.83 | |
| HR3 | 1.0 (Ref.) | 0.97 (0.81, 1.15) | 0.99 (0.91, 1.07) | 1.01 (0.91, 1.11) | 0.08 | 0.40 | |
ASR, age-standardized rate; CI, confidence interval; HR, hazard ratio.
HR1 was adjusted for age (continuous), area (for JPHC-I, JPHC-II only). HR2 and 3: further adjusted for total energy intake (quintile), smoking status (never, past, <19, 19–39, or ≥40 cigarettes/day), alcohol consumption (non, occasional, <23, 23–45, or ≥46 g ethanol/day), body mass index in kg/m2 (14–18.9, 19–20.9, 21–22.9, 23–24.9, 25–26.9, 27–29.9, or 30–40 kg/m2), history of diabetes mellitus (yes or no), and screening examination (yes or no; any kind of the following cancer screening for JPHC-I: chest X-ray, sputum test, photofluorography, gastrointestinal endoscopy, fecal occult blood test, barium enema, or colonoscopy; any kind of screening examination for JPHC-II; and chest X-ray, gastric cancer examination, Pap smear, mammography, or complete medical checkup for MIYAGI and OHSAKI). HR3 excluded diagnosed or deceased cases of any cancers during the first 3 years of follow-up. Linear trends across quintiles of fruit and vegetable intake were tested using 0 to 4 for each quintile as an ordinal variable.
Pooled analysis of total cancer incidence according to frequency of fruit and vegetable intake among 133,350 Japanese women, 1990–2006.
| Almost never | 1-2/week | 3-4/week | Almost daily | p for trend | p for heterogeneity | ||
|---|---|---|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | for the highest category | For trend | ||
| Number of subjects | 1035 | 1347 | 1944 | 127,745 | |||
| Person-years | 10,492 | 15,843 | 22,634 | 1,498,738 | |||
| Number of cases | 79 | 79 | 134 | 8324 | |||
| ASR (per 100,000) | 676 | 459 | 645 | 585 | |||
| HR1 | 1.0 (Ref.) | 0.69 (0.5, 0.97) | 0.97 (0.66, 1.44) | 0.87 (0.67, 1.14) | 0.28 | 0.69 | |
| HR2 | 1.0 (Ref.) | 0.69 (0.49, 0.97) | 0.96 (0.66, 1.4) | 0.88 (0.67, 1.15) | 0.27 | 0.55 | |
| HR3 | 1.0 (Ref.) | 0.67 (0.45, 1) | 0.97 (0.6, 1.57) | 0.90 (0.64, 1.27) | 0.20 | 0.20 | |
| Number of subjects | 12,464 | 13,402 | 22,478 | 84,523 | |||
| Person-years | 143,440 | 162,964 | 271,785 | 978,385 | |||
| Number of cases | 871 | 880 | 1354 | 5568 | |||
| ASR (per 100,000) | 610 | 599 | 548 | 588 | |||
| HR1 | 1.0 (Ref.) | 0.94 (0.85, 1.04) | 0.89 (0.82, 0.98) | 0.93 (0.87, 1.00) | 0.93 | 0.88 | |
| HR2 | 1.0 (Ref.) | 0.95 (0.86, 1.05) | 0.90 (0.82, 0.99) | 0.95 (0.88, 1.02) | 0.93 | 0.74 | |
| HR3 | 1.0 (Ref.) | 0.92 (0.82, 1.03) | 0.90 (0.81, 1.00) | 0.95 (0.87, 1.03) | 1.00 | 0.93 | |
| Number of subjects | 14,619 | 12,474 | 17,730 | 56,108 | |||
| Person-years | 175,283 | 160,159 | 230,565 | 680,397 | |||
| Number of cases | 1000 | 851 | 1168 | 3791 | |||
| ASR (per 100,000) | 596 | 630 | 580 | 584 | |||
| HR1 | 1.0 (Ref.) | 0.99 (0.90, 1.10) | 0.93 (0.83, 1.04) | 0.96 (0.89, 1.03) | 0.99 | 0.98 | |
| HR2 | 1.0 (Ref.) | 1.00 (0.90, 1.10) | 0.94 (0.84, 1.06) | 0.97 (0.91, 1.05) | 0.97 | 0.92 | |
| HR3 | 1.0 (Ref.) | 0.97 (0.87, 1.08) | 0.95 (0.83, 1.08) | 0.97 (0.89, 1.05) | 1.00 | 0.89 | |
| Number of subjects | 1874 | 2305 | 4164 | 123,992 | |||
| Person-years | 20,199 | 27,103 | 49,354 | 1,454,268 | |||
| Number of cases | 138 | 137 | 296 | 8068 | |||
| ASR (per 100,000) | 598 | 577 | 646 | 584 | |||
| HR1 | 1.0 (Ref.) | 0.84 (0.66, 1.07) | 1.09 (0.77, 1.56) | 0.91 (0.73, 1.15) | 0.21 | 0.73 | |
| HR2 | 1.0 (Ref.) | 0.84 (0.66, 1.07) | 1.09 (0.77, 1.54) | 0.92 (0.72, 1.18) | 0.17 | 0.51 | |
| HR3 | 1.0 (Ref.) | 0.92 (0.68, 1.23) | 1.08 (0.8, 1.46) | 1.01 (0.74, 1.37) | 0.14 | 0.29 | |
| Number of subjects | 3953 | 3416 | 11,615 | 113,897 | |||
| Person-years | 44,361 | 39,777 | 138,591 | 1,334,133 | |||
| Number of cases | 281 | 240 | 763 | 7397 | |||
| ASR (per 100,000) | 591 | 653 | 595 | 581 | |||
| HR1 | 1.0 (Ref.) | 1.08 (0.76, 1.54) | 0.94 (0.74, 1.2) | 0.91 (0.75, 1.12) | 0.10 | 0.69 | |
| HR2 | 1.0 (Ref.) | 1.09 (0.77, 1.53) | 0.94 (0.73, 1.21) | 0.92 (0.74, 1.15) | 0.07 | 0.61 | |
| HR3 | 1.0 (Ref.) | 1.15 (0.79, 1.68) | 0.99 (0.78, 1.26) | 0.94 (0.73, 1.22) | 0.05 | 0.33 | |
| Number of subjects | 7217 | 10,283 | 24,528 | 91,010 | |||
| Person-years | 78,742 | 112,495 | 278,824 | 1,088,495 | |||
| Number of cases | 503 | 644 | 1556 | 5988 | |||
| ASR (per 100,000) | 606 | 570 | 596 | 581 | |||
| HR1 | 1.0 (Ref.) | 0.93 (0.82, 1.05) | 0.96 (0.87, 1.07) | 0.93 (0.85, 1.02) | 0.63 | 0.49 | |
| HR2 | 1.0 (Ref.) | 0.93 (0.80, 1.07) | 0.97 (0.88, 1.08) | 0.95 (0.86, 1.04) | 0.50 | 0.58 | |
| HR3 | 1.0 (Ref.) | 0.90 (0.75, 1.08) | 0.96 (0.85, 1.08) | 0.94 (0.84, 1.04) | 0.46 | 0.52 | |
ASR, age-standardized rate; CI, confidence interval; HR, hazard ratio.
HR1 was adjusted for age (continuous), area (for JPHC-I, JPHC-II only). HR2 and 3: further adjusted for total energy intake (quintile), smoking status (never, past, or current), alcohol consumption (non, occasional, <23, 23–45, or ≥46 g ethanol/day), body mass index in kg/m2 (14–18.9, 19–20.9, 21–22.9, 23–24.9, 25–26.9, 27–29.9, or 30–40 kg/m2), history of diabetes mellitus (yes or no), and screening examination (yes or no; any kind of the following cancer screening for JPHC-I: chest X-ray, sputum test, photofluorography, gastrointestinal endoscopy, fecal occult blood test, barium enema, or colonoscopy; any kind of screening examination for JPHC-II; and chest X-ray, gastric cancer examination, Pap smear, mammography, or complete medical checkup for MIYAGI and OHSAKI). HR3 excluded diagnosed or deceased cases of any cancers during the first 3 years of follow-up. Linear trends across quintiles of fruit and vegetable intake were tested using 0 to 4 for each quintile as an ordinal variable.